Gardasil9

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Cervical CancerPapillomaHuman Papilloma Virus

115 competitors in Cervical Cancer

#DrugCompanyPhaseTrials

1

Taxol

Teva

Phase 3

452

Avastin

Roche

Phase 3

223

Paraplatin

AAvyxa

Phase 3

364

Keytruda

Merck & Co.

Phase 3

125

Trodelvy

Gilead

Phase 3

56

Lenvima

Eisai

Phase 3

37

Taxotere

AAvyxa

Phase 3

68

Albumin-Bound Paclitaxel

Bristol-Myers Squibb

Phase 3

29

Sacituzumab Tirumotecan

Merck & Co.

Phase 3

210

Rescue

Merck & Co.

Phase 3

1Show 37 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Papilloma3 trials

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

Active, not recruiting·MMassachusetts General Hospital·Phase 4·NCT06436274·778 enrolled

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Completed·XXiamen University·Phase 3·NCT04782895·488 enrolled

Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*

Not yet recruiting·OOhio State University·Phase 1/2·NCT07339163·50 enrolled

Immunogenicity2 trials

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Unknown status·SSinocelltech Ltd.·Phase 1·NCT04921111·240 enrolled

A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)

Active, not recruiting·Merck & Co.·Phase 1·NCT06688058·72 enrolled

HPV Vaccination2 trials

Postpartum HPV Vaccination

Completed·UUniversity of Alabama at Birmingham·Phase 4·NCT03451071·195 enrolled

HPV Vaccination Study in Postpartum Women

Completed·JJohns Hopkins University·Phase 4·NCT04274153·225 enrolled

Cervical Cancer1 trial

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Recruiting·MMiriam Elfström·Phase 4·NCT04910802·150,000 enrolled

Antibody1 trial

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Active, not recruiting·XXiamen University··NCT06197802·392 enrolled

3 more indications

Phase II1 trial

A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Unknown status·SSinocelltech Ltd.·Phase 2·NCT05060484·1,800 enrolled

Human Papilloma Virus1 trial

An Open-Label Clinical Trial Evaluating the Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Over a Four-year Follow up Among Children 4 to 8 Years Old, An Exploratory Immunogenicity Study

Active, not recruiting·BBoston Medical Center·Phase 1·NCT05329961·155 enrolled

Unspecified2 trials

A Phase 1, Randomized, Double-Blind, Comparator-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of V540B in Healthy Adults.

Recruiting·Merck & Co.·Phase 1·NCT06623409·72 enrolled

A Phase 2, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V540A in Healthy Females 16 to 26 Years of Age

Withdrawn·Merck & Co.·Phase 2·NCT07224477

Details

Drug Info

Related News